Engineering of Cas12a nuclease variants with enhanced genome-editing specificity

被引:3
|
作者
Chen, Peng [1 ]
Zhou, Jin [1 ]
Liu, Huan [1 ]
Zhou, Erchi [2 ]
He, Boxiao [1 ]
Wu, Yankang [1 ]
Wang, Hongjian [1 ]
Sun, Zaiqiao [1 ]
Paek, Chonil [1 ,3 ]
Lei, Jun [1 ]
Chen, Yongshun [1 ]
Zhang, Xinghua [2 ]
Yin, Lei [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Coll Life Sci, Dept Clin Oncol,State Key Lab Virol,Hubei Key Lab, Wuhan, Peoples R China
[2] Wuhan Univ, Inst Adv Studies, Coll Life Sci, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Wuhan, Peoples R China
[3] KIM IL SUNG Univ, Fac Life Sci, Pyongyang, North Korea
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
WIDE TARGET SPECIFICITIES; CRISPR-CAS9; NUCLEASES; CPF1; ENDONUCLEASE; MUTAGENESIS; CLEAVAGE; SPCAS9;
D O I
10.1371/journal.pbio.3002514
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The clustered regularly interspaced short palindromic repeat (CRISPR)-Cas12a system is a powerful tool in gene editing; however, crRNA-DNA mismatches might induce unwanted cleavage events, especially at the distal end of the PAM. To minimize this limitation, we engineered a hyper fidelity AsCas12a variant carrying the mutations S186A/R301A/T315A/Q1014A/K414A (termed HyperFi-As) by modifying amino acid residues interacting with the target DNA and crRNA strand. HyperFi-As retains on-target activities comparable to wild-type AsCas12a (AsCas12aWT) in human cells. We demonstrated that HyperFi-As has dramatically reduced off-target effects in human cells, and HyperFi-As possessed notably a lower tolerance to mismatch at the position of the PAM-distal region compared with the wild type. Further, a modified single-molecule DNA unzipping assay at proper constant force was applied to evaluate the stability and transient stages of the CRISPR/Cas ribonucleoprotein (RNP) complex. Multiple states were sensitively detected during the disassembly of the DNA-Cas12a-crRNA complexes. On off-target DNA substrates, the HyperFi-As-crRNA was harder to maintain the R-loop complex state compared to the AsCas12aWT, which could explain exactly why the HyperFi-As has low off-targeting effects in human cells. Our findings provide a novel version of AsCas12a variant with low off-target effects, especially capable of dealing with the high off-targeting in the distal region from the PAM. An insight into how the AsCas12a variant behaves at off-target sites was also revealed at the single-molecule level and the unzipping assay to evaluate multiple states of CRISPR/Cas RNP complexes might be greatly helpful for a deep understanding of how CRISPR/Cas behaves and how to engineer it in future. Mismatches can induce unwanted cleavage events and off-target effects in CRISPR-Cas12a-based gene editing. In this study, a high-fidelity AsCas12a variant was engineered by modifying amino acids that interact with the target DNA and crRNA strand, which has improved targeting specificity at both the proximal and distal region from the target recognition sequence.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] Small molecule-triggered Cas9 protein with improved genome-editing specificity
    Davis, Kevin M.
    Pattanayak, Vikram
    Thompson, David B.
    Zuris, John A.
    Liu, David R.
    NATURE CHEMICAL BIOLOGY, 2015, 11 (05) : 316 - U97
  • [32] Programmed genome editing by a miniature CRISPR-Cas12f nuclease
    Wu, Zhaowei
    Zhang, Yifei
    Yu, Haopeng
    Pan, Deng
    Wang, Yujue
    Wang, Yannan
    Li, Fan
    Liu, Chang
    Nan, Hao
    Chen, Weizhong
    Ji, Quanjiang
    NATURE CHEMICAL BIOLOGY, 2021, 17 (11) : 1132 - 1138
  • [33] Programmed genome editing by a miniature CRISPR-Cas12f nuclease
    Zhaowei Wu
    Yifei Zhang
    Haopeng Yu
    Deng Pan
    Yujue Wang
    Yannan Wang
    Fan Li
    Chang Liu
    Hao Nan
    Weizhong Chen
    Quanjiang Ji
    Nature Chemical Biology, 2021, 17 : 1132 - 1138
  • [34] Small molecule-triggered Cas9 protein with improved genome-editing specificity
    Davis K.M.
    Pattanayak V.
    Thompson D.B.
    Zuris J.A.
    Liu D.R.
    Nature Chemical Biology, 2015, 11 (5) : 316 - 318
  • [35] Cas12a CRISPR Hybrid RNA-DNA (chRDNA)-Mediated In Vivo Genome-Editing Technology for Efficient and Functional Hepatic Gene Disruption
    Losa-Llabata, Marta
    Rajmane, Prachi
    Stanaway, Liz
    Coons, Mary
    Munoz, Antonio
    Garish, Vaibhavi
    Donohoue, Paul
    Gradia, Scott
    Kanner, Steven
    Rahdar, Meghdad
    MOLECULAR THERAPY, 2024, 32 (04) : 149 - 149
  • [36] Combined genome editing and transcriptional repression for metabolic pathway engineering in Corynebacterium glutamicum using a catalytically active Cas12a
    Wei Liu
    Dandan Tang
    Haijiao Wang
    Jiazhang Lian
    Lei Huang
    Zhinan Xu
    Applied Microbiology and Biotechnology, 2019, 103 : 8911 - 8922
  • [37] Combined genome editing and transcriptional repression for metabolic pathway engineering in Corynebacterium glutamicum using a catalytically active Cas12a
    Liu, Wei
    Tang, Dandan
    Wang, Haijiao
    Lian, Jiazhang
    Huang, Lei
    Xu, Zhinan
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (21-22) : 8911 - 8922
  • [38] When size matters: A novel compact Cas12a variant for in vivo genome editing
    Bubeck, Felix
    Grimm, Dirk
    PLOS BIOLOGY, 2024, 22 (07)
  • [39] High-efficiency genome editing by Cas12a ribonucleoprotein complex in Euglena gracilis
    Nomura, Toshihisa
    Kim, June-Silk
    Ishikawa, Marumi
    Suzuki, Kengo
    Mochida, Keiichi
    MICROBIAL BIOTECHNOLOGY, 2024, 17 (02):
  • [40] Expanding the CRISPR/Cas genome-editing scope in Xenopus tropicalis
    Zhaoying Shi
    Hao Jiang
    Guanghui Liu
    Songyuan Shi
    Xuan Zhang
    Yonglong Chen
    Cell & Bioscience, 12